Relief Therapeutics Valuation

RLF Stock  CHF 1.34  0.05  3.88%   
Today, the company appears to be undervalued. Relief Therapeutics holds a recent Real Value of ₣1.4 per share. The prevailing price of the company is ₣1.34. Our model determines the value of Relief Therapeutics from analyzing the company fundamentals such as Return On Equity of -0.33, current valuation of 95.8 M, and Shares Owned By Insiders of 3.68 % as well as examining its technical indicators and probability of bankruptcy. In general, most investors support buying undervalued entities and disposing overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Undervalued
Today
1.34
Please note that Relief Therapeutics' price fluctuation is very risky at this time. Calculation of the real value of Relief Therapeutics is based on 3 months time horizon. Increasing Relief Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Relief Therapeutics Holding is useful when determining the fair value of the Relief stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Relief Therapeutics. Since Relief Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Relief Stock. However, Relief Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  1.34 Real  1.4 Hype  1.34 Naive  1.32
The real value of Relief Stock, also known as its intrinsic value, is the underlying worth of Relief Therapeutics Company, which is reflected in its stock price. It is based on Relief Therapeutics' financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Relief Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Relief Therapeutics' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.40
Real Value
4.22
Upside
Estimating the potential upside or downside of Relief Therapeutics Holding helps investors to forecast how Relief stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Relief Therapeutics more accurately as focusing exclusively on Relief Therapeutics' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1.231.291.35
Details
Hype
Prediction
LowEstimatedHigh
0.071.344.16
Details
Naive
Forecast
LowNext ValueHigh
0.031.324.14
Details

Relief Therapeutics Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Relief Therapeutics's current stock value. Our valuation model uses many indicators to compare Relief Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Relief Therapeutics competition to find correlations between indicators driving Relief Therapeutics's intrinsic value. More Info.
Relief Therapeutics Holding is currently regarded as top stock in price to earning category among related companies. It is rated second in price to book category among related companies . The ratio of Price To Earning to Price To Book for Relief Therapeutics Holding is about  363.99 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Relief Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Relief Therapeutics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Relief Therapeutics' earnings, one of the primary drivers of an investment's value.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Relief Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Relief Therapeutics and how it compares across the competition.

About Relief Therapeutics Valuation

The stock valuation mechanism determines the current worth of Relief Therapeutics Holding on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Relief Therapeutics Holding. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Relief Therapeutics based exclusively on its fundamental and basic technical indicators. By analyzing Relief Therapeutics's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Relief Therapeutics's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Relief Therapeutics. We calculate exposure to Relief Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Relief Therapeutics's related companies.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. RELIEF THERAPEUTICS operates under Pharmaceuticals And Biosciences classification in Switzerland and is traded on Switzerland Exchange. It employs 10 people.

8 Steps to conduct Relief Therapeutics' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Relief Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Relief Therapeutics' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Relief Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Relief Therapeutics' revenue streams: Identify Relief Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Relief Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Relief Therapeutics' growth potential: Evaluate Relief Therapeutics' management, business model, and growth potential.
  • Determine Relief Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Relief Therapeutics' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Relief Therapeutics Holding. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
Note that the Relief Therapeutics information on this page should be used as a complementary analysis to other Relief Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Relief Stock analysis

When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Stocks Directory
Find actively traded stocks across global markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Please note, there is a significant difference between Relief Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Relief Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Relief Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.